FDA Relaxes Vaccine Storage Rules to Speed Up Rollout

February 26, 2021 by Daniel Mollenkamp
FDA Relaxes Vaccine Storage Rules to Speed Up Rollout
Empty vials of the Pfizer-BioNTech COVID-19 vaccine are seen at a vaccination center at the University of Nevada, Las Vegas in Las Vegas. (AP Photo/John Locher)

WASHINGTON – The Food and Drug Administration has relaxed the rules around storage and transportation for some coronavirus vaccines in order to speed up the vaccine rollout.

Frozen vials of Pfizer-BioNTech’s coronavirus vaccine will be allowed to be kept at “conventional temperatures” found in pharmaceutical freezers for up to two weeks, following data provided to the agency by the company. Typically, the FDA demands that undiluted vials be stored in an ultra-low temperature freezer between -80ºC to -60ºC (-112ºF to -76ºF), a written statement from the agency said. 

This will allow for more flexibility, according to the FDA. Health care providers will receive new fact sheets to reflect this update.

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said that the data Pfizer provided to the agency proves that the vaccines will remain stable at these less extreme temperatures for the two-week time period.

“The alternative temperature for transportation and storage will help ease the burden of procuring ultra-low cold storage equipment for vaccination sites and should help to get vaccines to more sites,” Marks said in a written comment.

In the U.S., 68.27 million doses of the vaccine were administered as of Thursday, Feb. 25, according to data estimates affiliated with Oxford University. An estimated 13.8% of the country, or 46.07 million people, have received at least one dose of a coronavirus vaccine. 

The Pfizer vaccine got an emergency authorization from the FDA in December. An estimate provided by the Department of Health and Human Services reported that the U.S. had purchased about $6 billion worth of Pfizer’s coronavirus vaccine as of Feb. 11.

The FDA has relaxed restrictions and oversights during the coronavirus, which has caused researchers to warn that the situation will need to be revisited after the coronavirus crisis is over to avoid the risk of weakening patient safety in the country. At the moment, however, vaccine rollout is a top priority for the agency.

A+
a-
  • FDA
  • Food and Drug Administration
  • health
  • Pfizer-BioNTech
  • supply chain
  • Transportation
  • vaccine storage
  • vaccine supply chain
  • In The News

    Health

    Voting

    Health

    December 8, 2023
    by Dan McCue
    FDA Approves a CRISPR-Based Medicine to Treat Sickle Cell Disease

    WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for... Read More

    WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for the treatment of sickle cell disease. The new treatment, called Casgevy, was manufactured by Vertex Pharmaceuticals, of Boston, Massachusetts, and CRISPR Therapeutics, of Switzerland, using a... Read More

    Chronic Fatigue Syndrome More Common Than Past Studies Suggest, CDC Says

    NEW YORK (AP) — Health officials on Friday released the first nationally representative estimate of how many U.S. adults have... Read More

    NEW YORK (AP) — Health officials on Friday released the first nationally representative estimate of how many U.S. adults have chronic fatigue syndrome: 3.3 million. The Centers for Disease Control and Prevention's number is larger than previous studies have suggested, and is likely boosted by some... Read More

    December 8, 2023
    by Tom Ramstack
    White House Threatens to Penalize Pharma Companies for High Prices

    WASHINGTON — The Biden administration announced a plan Thursday to lower prescription drug costs in a move that takes a... Read More

    WASHINGTON — The Biden administration announced a plan Thursday to lower prescription drug costs in a move that takes a tough stance toward pharmaceutical companies charging high prices. If the Federal Trade Commission determines the prices are unreasonable, the new policy allows the federal government to... Read More

    December 6, 2023
    by Dan McCue
    House Unanimously Passes Bill to Increase Mental Health Resources for Veterans’ Caregivers

    WASHINGTON — The House on Monday unanimously passed the Caregiver Outreach and Program Enhancement Act, which would increase mental health... Read More

    WASHINGTON — The House on Monday unanimously passed the Caregiver Outreach and Program Enhancement Act, which would increase mental health resources available to caregivers of America’s veteran population. Alternately known as the COPE Act, the bipartisan legislation sponsored by Reps. Chrissy Houlahan, D-Pa., and Jen Kiggans,... Read More

    December 6, 2023
    by Dan McCue
    HHS Unveils Next Steps to Enhance Cybersecurity of Health Care Records

    WASHINGTON — The bad guys in cyberspace want your health care records.  Between 2018 and 2022, there was a 93%... Read More

    WASHINGTON — The bad guys in cyberspace want your health care records.  Between 2018 and 2022, there was a 93% increase in large breaches in the health care sector, with a 278% increase in large breaches involving ransomware, according to the Department of Health and Human... Read More

    December 6, 2023
    by Dan McCue
    New Report Sheds Some Light on Rare Post-COVID Shot Syndrome

    NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but... Read More

    NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but chronic and debilitating condition some people report experiencing after getting a COVID-19 vaccination. The paper, which was posted on the preprint server medRxiv and has not... Read More

    News From The Well
    scroll top